Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

7 hours ago

Creative Minds: 'Go smash it like an avocado' is ...

She once dreamed of covering war zones, not crafting ad campaigns. But a surprising turn of events led this TBWA Australia creative director to a career where "smashing it like an avocado" became her unexpected motto.

10 hours ago

Price-gouging in Aussie supermarkets: Where does ...

As supermarket price wars heat up, Woolworths and Coles are losing ground to Aldi, according to data from YouGov.

11 hours ago

Gen AI will have a profound impact on agency ...

With clients increasingly handling business-as-usual tasks in-house, agency profitability is at risk unless agencies redefine the value of their creative services, says brand and marketing consultant Andreas Moellmann.

11 hours ago

Call for submissions: Do you want to be featured in ...

Campaign's weekly, fun-filled interview series with APAC creatives is now open for entries. No deadlines, just pure creativity. Get the details here.